Relationship between the MTHFR C677T polymorphism and essential hypertension: A clinical correlation study.
文献摘要
Background The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism affects homocysteine metabolism and may influence essential hypertension (EH), but the associated clinical phenotype in hyperhomocysteinemic patients remains unclear. We focused on differences between patients with the homozygous mutation (TT) genotype and those with non-TT genotypes. Methods A total of 30 patients with EH and hyperhomocysteinemia (Hcy≥15μmol/L) admitted to Jincheng General Hospital from March 1, 2025, to July 31, 2025, were enrolled. MTHFR gene polymorphisms were determined. According to the MTHFR C677T genotype, patients were assigned to the TT group and the non-TT group (CT and CC genotypes). Demographic characteristics, blood pressure measurements, and duration of hypertension of the two groups were recorded and compared. Biochemical measures including homocysteine (Hcy), folic acid, vitamin B12, blood lipids, and fasting blood glucose were measured. Pulse pressure, mean arterial pressure (MAP), pulse pressure index (PPI), and hypertension cumulative risk index were calculated. Spearman correlation analysis was used to examine associations between folic acid levels and Hcy, pulse pressure, and PPI. Results Compared with the non-TT group, the TT group had significantly higher concentrations of Hcy and vitamin B12, a significantly shorter hypertension duration, and significantly lower systolic blood pressure (SBP), pulse pressure, PPI, and hypertension cumulative load index. Spearman rank correlation analysis showed that folic acid levels correlated inversely with Hcy, pulse pressure, and PPI. Conclusions The association between the MTHFR C677T TT genotype and cardiovascular risk may be confounded by vitamin B12 nutritional status and disease duration, complicating interpretation of the genotype as a simple risk factor.